Whole Brain Radiation Therapy With Hippocampus-Sparing Simultaneous In-field Boost Using Helical Tomotherapy for Brain Metastases From Lung Adenocarcinoma: Early Volume Response and Dosimetric Evaluation

2013 ◽  
Vol 87 (2) ◽  
pp. S279
Author(s):  
K. Kim ◽  
B. Cho ◽  
H. Kim ◽  
J. Baek ◽  
H. Shin ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Brain Metastases ◽  
Lung Adenocarcinoma ◽  
Helical Tomotherapy ◽  
Whole Brain Radiation Therapy ◽  
Whole Brain ◽  
Whole Brain Radiation ◽  
Volume Response ◽  
Brain Radiation

scholarly journals A Case of Lung Adenocarcinoma with Multiple Intracranial Hemorrhages of Brain Metastases After Whole-brain Radiation Therapy

Haigan ◽  
2011 ◽  
Vol 51 (7) ◽  
pp. 825-829
Author(s):  
Shinji Nakamichi ◽  
Satoshi Hirano ◽  
Tetsuhiko Asao ◽  
Yuichiro Takeda ◽  
Haruhito Sugiyama ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Brain Metastases ◽  
Lung Adenocarcinoma ◽  
Whole Brain Radiation Therapy ◽  
Intracranial Hemorrhages ◽  
Whole Brain ◽  
Whole Brain Radiation ◽  
Brain Radiation

scholarly journals Pemetrexed and Whole-Brain Radiation Therapy for Treatment of Brain Metastases from Non Small-Cell Lung Adenocarcinoma: A Single Instituton Analysis

2012 ◽  
Vol 23 ◽  
pp. ix150
Author(s):  
C. Chargari ◽  
Y. Moussaid ◽  
C. Helissey ◽  
J. Jacob ◽  
O. Bauduceau ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Brain Metastases ◽  
Lung Adenocarcinoma ◽  
Small Cell ◽  
Whole Brain Radiation Therapy ◽  
Small Cell Lung ◽  
Whole Brain ◽  
Whole Brain Radiation ◽  
Brain Radiation

scholarly journals BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases

2020 ◽  
Vol 107 (3) ◽  
pp. 478-486
Author(s):  
Michelle M. Kim ◽  
Hemant A. Parmar ◽  
Matthew Schipper ◽  
Theresa Devasia ◽  
Madhava P. Aryal ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Brain Metastases ◽  
Phase 1 ◽  
Whole Brain Radiation Therapy ◽  
Whole Brain ◽  
Whole Brain Radiation ◽  
Brain Radiation

Incidence, timing, and treatment of new brain metastases after Gamma Knife surgery for limited brain disease: the case for reducing the use of whole-brain radiation therapy

2011 ◽  
Vol 115 (1) ◽  
pp. 37-48 ◽  
Author(s):  
Stephen Rush ◽  
Robert E. Elliott ◽  
Amr Morsi ◽  
Nisha Mehta ◽  
Jeri Spriet ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Brain Metastases ◽  
Gamma Knife ◽  
Gamma Knife Surgery ◽  
Whole Brain Radiation Therapy ◽  
Leptomeningeal Disease ◽  
Whole Brain ◽  
Whole Brain Radiation ◽  
Brain Radiation

Object In this paper, the authors' goal was to analyze the incidence, timing, and treatment of new metastases following initial treatment with 20-Gy Gamma Knife surgery (GKS) alone in patients with limited brain metastases without whole-brain radiation therapy (WBRT). Methods A retrospective analysis of 114 consecutive adults (75 women and 34 men; median age 61 years) with KPS scores of 60 or higher who received GKS for 1–3 brain metastases ≤ 2 cm was performed (median lesion volume 0.35 cm3). Five patients lacking follow-up data were excluded from analysis. After treatment, patients underwent MR imaging at 6 weeks and every 3 months thereafter. New metastases were preferentially treated with additional GKS. Indications for WBRT included development of numerous metastases, leptomeningeal disease, or diffuse surgical-site recurrence. Results The median overall survival from GKS was 13.8 months. Excluding the 3 patients who died before follow-up imaging, 12 patients (11.3%) experienced local failure at a median of 7.4 months. Fifty-three patients (50%) developed new metastases at a median of 5 months. Six (7%) of 86 instances of new lesions were symptomatic. Most patients (67%) with distant failures were successfully treated using salvage GKS alone. Whole-brain radiotherapy was indicated in 20 patients (18.3%). Thirteen patients (11.9%) died of neurological disease. Conclusions For patients with limited brain metastases and functional independence, 20-Gy GKS provides excellent disease control and high-functioning survival with minimal morbidity. New metastases developed in almost 50% of patients, but additional GKS was extremely effective in controlling disease. Using our algorithm, fewer than 20% of patients required WBRT, and only 12% died of progressive intracranial disease.

Response at 3–months after whole brain radiation therapy predicts survival in brain metastases patients

2004 ◽  
Vol 60 ◽  
pp. S409-S409
Author(s):  
B STEA ◽  
J SUH ◽  
A NABID ◽  
A BOYD ◽  
J HACKMAN ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Brain Metastases ◽  
Whole Brain Radiation Therapy ◽  
Whole Brain ◽  
Whole Brain Radiation ◽  
Brain Radiation

Results of whole brain radiation therapy in breast cancer patients with brain metastases

2001 ◽  
Vol 51 (3) ◽  
pp. 132-133
Author(s):  
A.S. Mahmoud-ahmed ◽  
J.H. Suh ◽  
S.Y. Lee ◽  
R.L. Crownover ◽  
G.H. Barnett
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Brain Metastases ◽  
Cancer Patients ◽  
Whole Brain Radiation Therapy ◽  
Breast Cancer Patients ◽  
Whole Brain ◽  
Whole Brain Radiation ◽  
Brain Radiation

Fatigue Scores in Patients With Brain Metastases Receiving Whole Brain Radiation Therapy

2013 ◽  
Vol 87 (2) ◽  
pp. S90
Author(s):  
L. Khan ◽  
M. Tsao ◽  
N. Pulenzas ◽  
L. Zhang ◽  
N. Thavarajah ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Brain Metastases ◽  
Whole Brain Radiation Therapy ◽  
Whole Brain ◽  
Whole Brain Radiation ◽  
Brain Radiation
Sign in / Sign up

Export Citation Format

Share Document